This review summarizes recent advances in our understanding of the biological roles of TGFβ family factors in pluripotent stem cells and discusses how TGFβ family signaling pathways are involved in perturbations in the regulatory network of teratocarcinoma stem cells, which are the malignant counterparts of pluripotent stem cells. This evidence concerns the gene TGFB1 and teratocarcinoma.